AI Summary
✦ ClarthaValuation Metrics
Trading 16.7% below historical median. Valuation is declining — currently in the strongly undervalued zone (z-score: -0.79). Confidence: 72%.
Live forward EPS implies next-12-month EPS of ₹101.95. Applying the stock's normalized valuation corridor produces a fair range of ₹1,654.65 to ₹2,859.70, with base value near ₹2,110.36 (+90.7% vs current price).
Live forward estimate anchored to the company's historical valuation corridor.
Forward EPS
₹101.95
Forward P/E
10.9x
Base Fair Value
₹2,110.36
Fair Range
₹1,654.65 - ₹2,859.70
Upside To Base
+90.7%
Estimate Source
Live forward EPS
Growth Estimate
-37.9%
5Y Average
20.03
Current
17.24
Overvalued
28.05
Undervalued
16.23
5Y Average
10.83
Current
9.32
Overvalued
13.67
Undervalued
8.12
5Y Average
2.94
Current
2.15
Overvalued
3.39
Undervalued
2.50
Peers & Comparison
Sector: Materials · Theme: Commodity Chemicals
| Company | Rev. Growth | Margin | P/E | vs Avg | 52W Perf. |
|---|---|---|---|---|---|
INDIA GLYCOLS LTD INDIAGLYCOCommodity Chemicals | +13.1% | 7.0% | 24.4x Undervalued | -33% vs avg | +19.3% |
GARWARE HI-TECH FILMS LTD GRWRHITECHCommodity Chemicals | +31.9% | 17.1% | 48.2x Premium | +33% vs avg | +144.1% |
EPIGRAL LIMITED trades at a discount (17.2x vs peer avg 36.3x), suggesting potential undervaluation relative to the Commodity Chemicals cohort. Peers include INDIA GLYCOLS LTD, GARWARE HI-TECH FILMS LTD — selected based on business model, industry classification, market cap similarity, and business theme alignment.
Financials
Real statement data for revenue, earnings quality, conversion, and balance-sheet coverage. Monetary values are shown in Rs crore.
Latest revenue
₹705 CrJun 2026Latest net profit
₹99 CrJun 2026Latest EPS
₹22.99Jun 2026Net margin
25.0%Jun 2026Performance
Bars show revenue and net profit. The line shows net margin.
- Revenue
- Net income
- Net margin %
Earnings
Revenue is shown in crores. EPS is rupees per share.
- Revenue
- EPS
Revenue to profit conversion
Bridge from operating numbers to profit for the latest reported period.
Latest reported period: Jun 2026
Debt level and coverage
Debt, cash and free cash flow compared on the same crore scale.
- Debt
- Free cash flow
- Cash & equivalents
Results
| Metric | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales + | 455 | 478 | 472 | 525 | 651 | 626 | 645 | 628 | 607 | 587 | 597 | 736 | 705 |
| Expenses + | 360 | 370 | 349 | 369 | 475 | 448 | 463 | 454 | 443 | 455 | 494 | 568 | 526 |
| Operating Profit | 95 | 108 | 123 | 155 | 176 | 178 | 183 | 173 | 163 | 132 | 103 | 169 | 179 |
| OPM % | 21% | 23% | 26% | 30% | 27% | 28% | 28% | 28% | 27% | 23% | 17% | 23% | 25% |
| Other Income + | 2 | 1 | 2 | 2 | 2 | 6 | 4 | 3 | 8 | 2 | 6 | -1 | 4 |
| Interest | 18 | 21 | 20 | 14 | 14 | 27 | -0 | 12 | 23 | 22 | 11 | 16 | 7 |
| Depreciation | 31 | 32 | 31 | 30 | 33 | 32 | 33 | 34 | 42 | 42 | 43 | 42 | 43 |
| Profit before tax | 48 | 56 | 74 | 113 | 131 | 124 | 154 | 131 | 107 | 70 | 55 | 111 | 133 |
| Tax % | 33% | 32% | 34% | 32% | 34% | 35% | 33% | 34% | -50% | 26% | 28% | 26% | 26% |
| Net Profit + | 32 | 38 | 49 | 77 | 86 | 81 | 104 | 87 | 160 | 52 | 39 | 82 | 99 |
| EPS in Rs | 7.62 | 9.18 | 11.87 | 18.45 | 20.70 | 19.38 | 24.00 | 20.08 | 37.18 | 11.94 | 9.07 | 18.99 | 22.99 |
| Raw PDF |
All values in ₹ Crores unless otherwise stated. Source: Screener Master (Standalone).
Events Timeline
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Announcement under Regulation 30 (LODR)-Earnings Call Transcript